LT
Latigo Biotherapeutics Inc.
LTGO · NASDAQ
$22.55 -6.74% (-$1.63)
1M +2.50%
Valuation
-
N/A P/B N/A
P/FFO N/A
P/E N/A
Growth
-
N/A Book val. growth N/A
FCF growth N/A
EPS growth N/A
Profitability
-
N/A FCF margin N/A
Op. margin N/A
Gross margin N/A
Quality
-
N/A Asset turnover N/A
ROA N/A
ROIC N/A
Debt
-
N/A Net debt/EBITDA N/A
Int. coverage N/A
Debt/Equity N/A
Stability
0 /100
Unstable Beta 0.00x
EPS volatility N/A
Profitable years N/A
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre LTGO
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Nima Farzan
Employees
59
Headquarters
Thousand Oak